Efg Asset Management (North America) Corp. Rocket Pharmaceuticals, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $585 Million
- Q3 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 244,420 shares of RCKT stock, worth $2.94 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
244,420
Previous 222,046
10.08%
Holding current value
$2.94 Million
Previous $4.78 Million
5.56%
% of portfolio
0.77%
Previous 0.84%
Shares
8 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$213 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$135 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$74.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$66.6 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$54.1 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $910M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...